Oncology Central

Managing Hodgkin lymphoma without chemotherapy: a novel, yet ‘welcomed’, challenge


The dawn of the past century saw the exploitation of radiation therapy in Hodgkin lymphoma (HL) and its ensuing cures in some of the treated patients. Subsequent developments in the study of malignant diseases, and an improved understanding of lymphoma growth, led to the discernment that a tailored approach is warranted in patients with HL. As such, this type of lymphoma is one of the most curable malignancies nowadays, with a 5-year overall survival exceeding 80% for all stages combined [1].




News Headlines

Leave A Comment

Please wait...

Would you like access to more immuno-oncology content?

Register with Oncology Central to find out the latest news, opinions and journal articles published in the oncology field by leading experts.